News | FFR Technologies | January 04, 2022

European Trial Evaluates Angiography Vessel Fractional Flow Reserve (vFFR) Guided PCI Versus Conventional FFR

Pie Medical Imaging CAAS vFFR non-invasive physiological assessment of intermediate coronary lesions is the subject of FAST III trial

The Pie Medical Imaging angiography-based vessel fractional flow reserve (CAAS vFFR) technology can use angiography imaging alone to assess FFR without the need for pressure wires or  adenosine.

The Pie Medical Imaging angiography-based vessel fractional flow reserve (CAAS vFFR) technology can use angiography imaging alone to assess FFR without the need for pressure wires or adenosine.


January 4, 2022 - Pie Medical Imaging (PMI), a global leader in cardiac imaging, part of the Esaote Group, recently announced the beginning of FASTIII, a multicenter randomized clinical trial investigating the use of angiography-based vessel fractional flow reserve (CAAS vFFR) in patients undergoing coronary revascularization procedures.  

The FASTIII trial is led by Dr. Joost Daemen, cardiologist at the Thoraxcenter at the Erasmus University Medical Center, Rotterdam, The Netherlands. It is an investigator initiated international, multi-center randomized, non-inferiority trial aiming to enroll a total of 2228 patients, in seven European countries and 35 hospitals and is sponsored by the European Cardiovascular Research Institute (ECRI)

The FAST III study aims to demonstrate non-inferiority of CAAS vFFR guided revascularization as compared to a conventional invasive wire based FFR guided revascularization in patients with either stable coronary syndrome or non-ST segment elevation myocardial infarction and intermediate coronary artery lesions.  

vFFR can assess whether a coronary artery narrowing is functionally severe and requires treatment. CAAS vFFR allows doing so without the need for adenosine or invasive wires that are part of the routine practice to measure FFR pressure gradients.

The high diagnostic accuracy of CAAS vFFR, which calculates pressure drop and vFFR value using angiography images only was recently confirmed by the results of FAST I, FAST Extend and FASTII studies which validated vFFR as an accurate and easy to use tool to assess coronary physiology. 

“We are confident that this new study will lead to a broader use of methods based on angiographic images for a safe and accurate assessment of severity and percentage of artery stenosis” said René Guillaume, PMI managing director. 

The trial is funded by research grants from Pie Medical Imaging (Maastricht, the Netherlands) and Siemens Healthineers GmbH (Erlangen, Germany). 

For more information: www.piemedicalimaging.com 

 

Related Image-based FFR Technology Content:

Image-based FFR May Replace Pressure Wires and Adenosine

7 Trends in Interventional Lab Angiography Systems

New Technology Directions in Fractional Flow Reserve (FFR)

FAST Study Demonstrates High Diagnostic Accuracy of CAAS vFFR
 


Related Content

News | Cath Lab

May 16, 2023 — Royal Philips, a global leader in health technology, announced late-breaking data from the DCR4Contrast ...

Home May 16, 2023
Home
News | Cath Lab

March 14, 2023 — Royal Philips, a global leader in health technology, and the Gibraltar Health Authority, announced they ...

Home March 14, 2023
Home
News | Cath Lab

March 1, 2023 — SpectraWAVE, Inc., a medical imaging company focused on improving the treatment and outcomes for ...

Home March 01, 2023
Home
News | Cath Lab

May 31, 2022 — Innovative Health, LLC, a specialty cardiology reprocessor, announced that the company has received ...

Home May 31, 2022
Home
News | Cath Lab

May 26, 2022 — The U.S. Food and Drug Administration (FDA) has recalled the Dragonfly OpStar Imaging Catheter, and has ...

Home May 26, 2022
Home
News | Cath Lab
April 25, 2022 – NewYork-Presbyterian Hudson Valley Hospital celebrated the launch of its interventional cardiology ...
Home April 25, 2022
Home
News | Cath Lab
April 18, 2022 – Royal Philips and Oulu University Hospital (Finland) have announced a strategic 10-year partnership ...
Home April 18, 2022
Home
News | Cath Lab
February 16, 2022 – Fremont Bank Foundation recently donated $750,000 to its community partner, St. Rose Hospital ...
Home February 16, 2022
Home
News | Cath Lab
February 14, 2022 — A collaborative effort between The Valley Heart and Vascular Institute’s cardiology team ...
Home February 14, 2022
Home
Sponsored Content | Videos | Cath Lab

Advancements in analytics and data visualizations are helping to streamline operations and improve productivity at cath ...

Home January 13, 2022
Home
Subscribe Now